news 2016
« BACK
Chemistry - Administration - 12.05.2016
Life Sciences - Administration - 26.02.2016
Administration - Health - 19.01.2016
Administration
Results 1 - 3 of 3.
Hay fever’s hidden supporting substances
Research news Up to now, research into pollen allergies has largely focused on allergens - those components of pollen that trigger hypersensitivity reactions. When it comes into with the nasal mucous membrane, however, pollen releases a host of other substances in addition to allergens. In a pilot study, a team of researchers from the Technical University of Munich (TUM) and the Helmholtz Zentrum München investigated for the first time the effects of these substances on allergy sufferers.
Research news Up to now, research into pollen allergies has largely focused on allergens - those components of pollen that trigger hypersensitivity reactions. When it comes into with the nasal mucous membrane, however, pollen releases a host of other substances in addition to allergens. In a pilot study, a team of researchers from the Technical University of Munich (TUM) and the Helmholtz Zentrum München investigated for the first time the effects of these substances on allergy sufferers.
Highly Endowed Grant from European Research Council for Heidelberg Biologist
Heidelberg biologist Dr. Sylvia Erhardt is receiving a highly endowed grant from the European Research Council (ERC), an ERC Consolidator Grant for excellent young researchers.
Heidelberg biologist Dr. Sylvia Erhardt is receiving a highly endowed grant from the European Research Council (ERC), an ERC Consolidator Grant for excellent young researchers.
Almost ¤2 million in funding for Münster virologist
Dr. Mario Schelhaas from Münster University has seen off the competition to receive a grant from the European Research Council (ERC). The grant, worth up to two million euros, is particularly prestigious. Mario Schelhaas is a virologist and biochemist at the Institute of Molecular Virology and the Institute of Medical Biochemistry.
Dr. Mario Schelhaas from Münster University has seen off the competition to receive a grant from the European Research Council (ERC). The grant, worth up to two million euros, is particularly prestigious. Mario Schelhaas is a virologist and biochemist at the Institute of Molecular Virology and the Institute of Medical Biochemistry.